New trial data for the drug Donanemab [[don-AHN-eh-mab]] has shown it to slow the progression of memory and thinking problems by about a third.
Alzheimer’s treatment: A new hope?
A PET brain scan from a US Alzheimer's Institute (AAP).
A treatment for Alzheimer's might be getting closer. An international study has found an experimental drug can slow progression of memory and thinking problems. But the medicine works best when patients are treated early.
Share
